Clinical trial
Development of Antibody-Based Diagnostic Markers for Abnormal Cervical Cells
NCT00004091 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of Antibody-Based Diagnostic Markers for Abnormal Cervical Cells
- Lead sponsor
- Northwestern University
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 1999
- Completion date
- February 28, 2001
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cervical cancer